Advancing Supply Chain Resilience in Europe’s O...

By HEOR Staff Writer

April 28, 2026

In an interview with Adrian van den Hoven, Director General of Medicines for Europe, meaningful progress made in 2025 is highlighted, ...
Advancing Subcutaneous Diuretic Therapy for Heart Failure Management
TikTok Opioid Overdose Forecasting: Leveraging Social Media Data for Enhanced...
Enhancing Breakthrough Medical Device Access: EMA’s New Pilot Program f...
Medical Device Innovation South Africa: Breaking Down Systemic Barriers
Expanding Access to Hormonal IUDs in South Africa through Generic Innovation
Regulatory Divergence in PSMA Targeted Therapy: Implications for European Mar...
PIONEER TEENS Trial Reveals Oral Semaglutide Diabetes Breakthrough for Pediat...
Terminal Complement Inhibition: Promising Results in IgAN from the I CAN Trial
Advancing Multicenter AKI Prediction: Benefits of Collaborative Models Over L...
Advancements in Rare Disease Therapies: CHMP’s April 2026 Insights and ...
Europe Pharmaceutical Access at a Critical Crossroads Amid U.S. Pricing Policies
Economic Impact of Fragmented Care: Tackling Obesity, Diabetes, and Cardiovas...